Postprandial C-Peptide (pCP) in Provider-Diagnosed Pediatric Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D)

被引:0
|
作者
Redondo, Maria J.
Harrall, Kylie K.
Bird, Sarah M.
Tosur, Mustafa
Uysal, Serife
Siller, Alejandro F.
Velasquez, Horacio J.
Muir, Andrew
Vehik, Kendra
Brusko, Todd M.
Atkinson, Mark A.
Dabelea, Dana
Hagopian, William
Oram, Richard A.
机构
基金
美国国家卫生研究院;
关键词
D O I
10.2337/db24-1318-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1318-P
引用
收藏
页数:2
相关论文
共 50 条
  • [41] The COVID-19 pandemic and Type 1 Diabetes (T1D): effect of the second wave on newly diagnosed children with T1D
    Othmana, F.
    Al-Juaillab, F.
    Al-Qaisic, T.
    Al-Kandaric, A.
    Al-Abdulrazzaqb, D.
    Al-Kandaria, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [42] Practice Patterns of Medical Management of Pediatric Obesity and Type 1 Diabetes (T1D)
    Doolan, Jade
    Isganaitis, Elvira M.
    Laffel, Lori M.
    Maxwell, Tara K.
    DIABETES, 2024, 73
  • [43] Frequency of Self-Monitoring of Blood Glucose (SMBG) and A1C Levels in Youth with Type 2 Diabetes (T2D): Data from the Pediatric Diabetes Consortium (PDC) T2D Registry Consortium (PDC) T2D Registry
    Haller, Michael J.
    Cengiz, Eda
    Tamborlane, William V.
    Roy, Sani
    Thambundit, Apisadaporn
    Beck, Roy W.
    Kollman, Craig
    Ruedy, Katrina
    Connor, Crystal
    Buckingham, Bruce
    Gregg, Brigid
    Thomas, Inas
    DIABETES, 2014, 63 : A390 - A390
  • [44] Elevated Serum IgA and the Gut Microbiome in Pediatric Type 1 Diabetes (T1D)
    Thakkar, Amruta
    Redondo, Maria J.
    Hajjar, Joud
    Petrosino, Joseph
    Hoffman, Kristi L.
    Cormier, Juwan
    Ahmed, Maaz
    Huang, Xiaofan C.
    DIABETES, 2023, 72
  • [46] Characteristics of Pediatric Type 1 Diabetes (T1D) that Predict HbA1c at One Year
    Redondo, Maria J.
    Wong-Jacobson, Siew
    Buckingham, Bruce
    Kollman, Craig
    Klingensmith, Georgeanna J.
    Silverstein, Janet H.
    Tamborlane, William
    Wood, Jamie
    DIABETES, 2012, 61 : A329 - A330
  • [47] Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials
    Ismail, Heba M.
    Bundy, Brian N.
    Atkinson, Mark A.
    Moore, Wayne V.
    Haller, Michael J.
    Russell, William E.
    Gitelman, Stephen E.
    Herold, Kevan C.
    Redondo, Maria Jose
    Sosenko, Jay M.
    DIABETES, 2019, 68
  • [48] A 2-Dimensional (2D) Analysis of Glucose and C-Peptide Shows a Teplizumab Effect in Individuals at Risk for Type 1 Diabetes (T1D) 3 Months after Treatment
    Sims, Emily K.
    Warnock, Megan V.
    Herold, Kevan C.
    Sosenko, Jay
    DIABETES, 2020, 69
  • [49] Early Trauma Responses after Child Newly Diagnosed with Type 1 Diabetes (T1D)
    Ambrosino, Jodie M.
    Weinzimer, Stuart A.
    Santacroce, Sheila
    Tamborlane, William V.
    Grey, Margaret
    DIABETES, 2009, 58 : A477 - A477
  • [50] Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry
    Aleppo, Grazia
    Calhoun, Peter
    Foster, Nicole C.
    Maahs, David M.
    Shah, Viral N.
    Miller, Kellee M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (12) : 1669 - 1673